12 Health Care Stocks Moving In Monday's Intraday Session
Decoy Therapeutics Inc DCOY
$4.11
▲ +4.85%
(+$0.19)
🎈 Low Float
🗓️ Earnings Next Week
Open
$3.97
Prev Close
$3.92
Day Range
$3.85 – $4.12
52W Range
$3.51 – $131.40
Market Cap
$2.43M
Beta
0.57
EPS (TTM)
$-1,011.67
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2015-01-29 |
| Shares Out. | 530,000 |
| Website | salariuspharma.com/ ↗ |
| Phone | 13026587581 |
| Employees | 11 |
| Net Income | -$2.2M |
| Free Cash Flow | -$7.1M |
| Total Assets | $8.4M |
| Total Liabilities | $4.5M |
| Equity | $3.9M |
About Decoy Therapeutics Inc
Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.
Decoy Therapeutics Inc is a publicly traded company under the ticker symbol DCOY on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2025-01-01)